Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT201111291414N28
IRCT201111291414N28
Completed
Early Phase 1

Investigation on autologous mesenchymal stem cell transplantation in diabetic nephrophaty (type one)

Endocrinology and Metabolism Research Institute (EMRI)0 sites20 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsDiabetes Nephropathy (type 1).Glomerular disorders in diabetes mellitus

Overview

Phase
Early Phase 1
Intervention
Not specified
Conditions
Diabetes Nephropathy (type 1).
Sponsor
Endocrinology and Metabolism Research Institute (EMRI)
Enrollment
20
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Endocrinology and Metabolism Research Institute (EMRI)

Eligibility Criteria

Inclusion Criteria

  • •1\.signing informed consent
  • •2\.People with diabetes type one with at least 10 years duration
  • •3\.age 18\-40 years
  • •4\.Diabetic nephropathy diagnosed by nephrologists
  • •5\.HbA1c \= 7\.5% (blood glucose is controlled at least for one month)
  • •Exclusion criteria:
  • •1\.acute vascular inflammation
  • •2\.acute thrombosis (three months)
  • •3\. recent bleeding in the retina (the last three months)
  • •4\. pulmonary hypertension

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Early Phase 1
Investigation on autologous mesenchymal stem cell transplantation in diabetic retinopathydiabetic retinopathy (dibetes type one).Diabetic retinopathyH36.0*
IRCT201111291414N29The EMRI Endocrinology and Metabolism Research Institute ? Tehran University of Medical Sciences20
Completed
Phase 2
Effect of mesenchymal stem cells transplantation to improve of diabetic neuropathyDiabetic neurophaty.Diabetic polyneuropathy (E10-E14 with common fourth character .4+)G63.2*
IRCT201103171414N23???Endocrinology & Metabolism Research Institute Tehran University Of Medical Sciences20
Active, not recruiting
Phase 1
SMART-MSMultiple sclerosisMedDRA version: 20.1Level: PTClassification code: 10028245Term: Multiple sclerosis Class: 100000004852Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
CTIS2023-510228-63-00Helse Bergen HF18
Not yet recruiting
Phase 2
SMART-MS
2023-510228-63-00Helse Bergen HF18
Completed
Not Applicable
Mesenchymal stem cell transplantation in the treatment of type 1 diabetic patientsType 1 diabetes.Insulin-dependent diabetes mellitus
IRCT138810271414N8Endocrinology & Metabolism Research Center20